CSTL

Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting

Castle Biosciences Collaborates with the Melanoma Research Foundation

Castle Biosciences to Release Second Quarter 2021 Financial Results and Host Conference Call on Monday, Aug. 9, 2021

Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at SDPA Annual Summer Dermatology Conference 2021

Castle Biosciences Expands its Board of Directors with New Appointments

AltheaDx, Inc. appoints industry veteran Derek Maetzold to its Board of Directors

Castle Biosciences Supports the American Skin Association with Research Grant